15 completed, 6 terminated, 4 unknown, 3 withdrawn. 29 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 29 | Completed 15, Terminated 6, Unknown 4, Withdrawn 3, Recruiting 1 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome rhGH injection - Short Bowel Syndrome (SBS) in Adults | Phase 4 | Recruiting | Changchun GeneScience Pharmaceutical Co., Ltd. | 100 | 2024-07-31 | 2026-07-08 |
| Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) Ferinject, oral iron - Celiac Disease | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 1 | 2022-07-08 | 2026-07-09 |
| AN-PEP on Gluten Exposure in Celiacs Prolyl Endopeptidase, Placebo - Celiac Disease | Phase 4 | Completed | Dr. C. Bonorino Udaondo Gastroenterology Hospital | 40 | 2021-03-17 | 2023-02-24 |
| Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A) Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD) | Phase 4 | Completed | Baxter Healthcare Corporation | 101 | 2021-01-22 | 2023-12-27 |
| Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition Apixaban single dose, Apixaban steady-state - Short Bowel Syndrome, Anticoagulation | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 70 | 2020-12-20 | 2026-10-15 |
| Budesonide in Patients With Immune Mediated Enteropathies Withdrawal of Oral Budesonide - Enteropathy, Celiac Disease | Phase 4 | Terminated | Mayo Clinic | 1 | 2019-09-10 | 2022-08-26 |
| Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients Probiotic Vivomixx, Gluten free diet, Placebo - Celiac Disease | Phase 4 | Unknown | University of Milan | 90 | 2019-01-30 | 2021-02-10 |
| Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients Teduglutide - Short Bowel Syndrome | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 25 | 2018-07-02 | 2025-09-11 |
| Differences in Preparation for Small Bowel Capsule Endoscopy Klean Prep, Clear liquids only - Capsule Endoscopy, Inflammatory Bowel Diseases | Phase 4 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 230 | 2017-11-23 | 2026-05-01 |
| SMOFLipid in Patients Who Are Intralipid Intolerant SMOFLipid, Standard therapy - Home Parenteral Nutrition, Short Bowel Syndrome | Phase 4 | Withdrawn | Mayo Clinic | 2017-02-01 | 2018-03-22 | |
| Prucalopride Prior to Small Bowel Capsule Endoscopy Prucalopride, Placebo - Gastrointestinal Hemorrhage, Crohn Disease | Phase 4 | Unknown | University of British Columbia | 122 | 2016-07-01 | 2016-07-15 |
| Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism L-Thyroxine (tablet, per os), L-Thyroxine (oral drops, solution) - Hypothyroidism | Phase 4 | Unknown | Meyer Children's Hospital IRCCS | 70 | 2016-05-01 | 2016-09-28 |
| Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People Oral consumption of milk with sequence A1-A2, Oral consumption of milk with sequence A2-A1 - Lactose Intolerance | Phase 4 | Completed | a2 Milk Company Ltd. | 600 | 2016-01-01 | 2016-08-25 |
| The Use of DPP-4 Inhibitors in Short Bowel Syndrome Dipeptidyl peptidase-4 inhibitor - Short Bowel Syndrome | Phase 4 | Terminated | Stanley Dudrick's Memorial Hospital | 8 | 2016-01-01 | 2020-04-15 |
| Feasibility Study of the Intensive Systolic Blood Pressure Control Standard BP control, Moderate BP control, Intensive BP control - Hypertension, Hyperhomocysteinemia | Phase 4 | Unknown | Second Affiliated Hospital of Nanchang University | 100 | 2015-12-01 | 2016-10-14 |
| Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance gaxilose, lactose - Lactose Intolerance | Phase 4 | Completed | VenterPharma | 1 | 2015-10-01 | 2016-12-28 |
| Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD) | Phase 4 | Terminated | Baxter Healthcare Corporation | 1 | 2015-05-01 | 2021-07-21 |
| Pancreatic Enzyme Supplementation for Celiac Disease pancrelipase - Celiac Disease | Phase 4 | Terminated | Beth Israel Deaconess Medical Center | 21 | 2015-05-01 | 2021-05-12 |
| rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome rtPA lock therapy - Short Bowel Syndrome | Phase 4 | Completed | Lynn Malec | 8 | 2015-02-01 | 2018-02-06 |
| Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior Oral consumption milk Tetra Pak - Lactose Intolerance | Phase 4 | Completed | a2 Milk Company Ltd. | 45 | 2014-10-01 | 2015-04-02 |
Showing 20 of 29. Sign in to see all of them.
Short Bowel Syndrome (13) · Celiac Disease (8) · Hyperhomocysteinemia (4) · Hyperphagia (4) · Lactose Intolerance (3) · Hypertension (2) · Inflammatory Bowel Diseases (2) · Intestinal Diseases (2) · Pena Shokeir syndrome, type 1 (2) · Autoimmune enteropathy (1) · Cardiovascular Diseases (1) · Collagenous Sprue (1) · Crohn Disease (1) · Cystic Fibrosis (1)
Digestive System Diseases (25) · Gastrointestinal Diseases (25) · Intestinal Diseases (23) · Metabolic Diseases (17) · Nutritional and Metabolic Diseases (17) · Pathological Conditions, Signs and Symptoms (17) · Pathologic Processes (16) · Postoperative Complications (13) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Genetic Diseases, Inborn (8) · Metabolism, Inborn Errors (7) · Nutrition Disorders (5) · Signs and Symptoms (5) · Amino Acid Metabolism, Inborn Errors (4)
Folic Acid (2) · Growth Hormone (2) · Standard of Care (2) · soybean oil, phospholipid emulsion (2) · teduglutide (2) · 4-O-galactopyranosylxylose (1) · ALX-0600 (1) · Amylases (1) · Angptl4 protein, mouse (1) · Diet Records (1) · Diet, Gluten-Free (1) · Dipeptidyl-Peptidase IV Inhibitors (1) · Enalapril (1) · Exenatide (1) · Hematologic Tests (1)
Mayo Clinic (4) · Assistance Publique - Hôpitaux de Paris (2) · Baxter Healthcare Corporation (2) · a2 Milk Company Ltd. (2) · Beth Israel Deaconess Medical Center (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Dr. C. Bonorino Udaondo Gastroenterology Hospital (1) · Forest Laboratories (1) · Jinling Hospital, China (1) · Lynn Malec (1) · Meyer Children's Hospital IRCCS (1) · Northwestern University (1) · Queen Sirikit National Institute of Child Health (1) · Second Affiliated Hospital of Nanchang University (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1)
United States (9) · China (4) · Canada (2) · France (2) · Italy (2) · Poland (2) · Argentina (1) · Belgium (1) · Brazil (1) · Germany (1) · Spain (1) · Thailand (1) · United Kingdom (1)
Andrew J Clarke, PhD (2) · Michael Camilleri, MD (2) · Altair J Mocelin, MD PHD (1) · Ciaran Kelly, MD (1) · Edgardo G Smecuol (1) · Fanfan Hou, MD (1) · Fedja Rochling, MB, ChB (1) · Fergal Donnellan, MD (1) · Jonathan Fryer, MD (1) · Joseph A Murray, MD (1) · Laura Crespo, MD, PhD (1) · Lynn Malec, MD (1)
PMID 25391194, PMID 26223941, PMID 27039383, PMID 27680716, PMID 29070042, PMID 30431582, PMID 32527283, PMID 36687454, PMID 37270289, PMID 40415417
2015 (2), 2017 (1), 2019 (1), UL1TR000135 (1)